Optic Neuritis Treatment Guidelines

First-Line Treatment Recommendations

The American Academy of Ophthalmology recommends high-dose intravenous methylprednisolone at 1000 mg/day for 3 days as the first-line treatment for optic neuritis, not hydrocortisone 1
Treatment should be initiated promptly, as delay beyond 2 weeks is associated with poorer outcomes 1
For optic neuritis associated with systemic lupus erythematosus, pulse IV methylprednisolone combined with IV cyclophosphamide is recommended 1
Refractory cases may require additional immunosuppressive options, including Rituximab, Azathioprine, and Plasma exchange 1

Topical corticosteroids like loteprednol 0.5% suspension or gel can be used with a slow taper for ocular surface inflammation 2
Topical corticosteroid drops, such as nonpreserved dexamethasone 0.1% twice daily, may reduce ocular surface damage in conditions like Stevens-Johnson syndrome 3
Topical glucocorticoids should be used for short-term therapy (≤3 months) due to potential ocular complications like elevated intraocular pressure and cataract formation 4

Regular ophthalmological evaluations, including visual acuity, visual fields, and funduscopy, are necessary to monitor treatment response 1
Daily ophthalmological review is necessary during acute illness in conditions with ocular involvement 3
Visual-evoked potentials may detect bilateral optic nerve damage before it becomes clinically apparent 1

MRI of the brain and orbits with contrast is essential for diagnosis and to rule out other conditions 1
Relapses are common (50-60%) during corticosteroid dose reduction, highlighting the need for maintenance immunosuppressive therapy in some cases 1
Using ≥4 drops daily of topical prednisolone increases the risk of developing cataracts compared to ≤3 drops daily 4